After an insane 1,882% rise in five years, Nvidia has been an incredible growth stock. I’ve been hunting for shares that could replicate this kind of performance. Here’s one potential contender — down 48% since I first invested — that I’d consider buying at $1 today. Programmable DNA The stock is Ginkgo ...
motleyfoolukusx:dna
Sometimes it pays to team up. That's what Novo Nordisk (NYSE: NVO) and Ginkgo Bioworks (NYSE: DNA) decided to do April 10 when they launched a new manufacturing collaboration that could benefit both companies. Details about the financial terms of their team-up are scarce, but there are at least a few ...
motleyfoolusx:nvousx:dna
Ginkgo Bioworks (NYSE: DNA) has a lot going for it. It's a favorite of Cathie Wood's Ark Innovation ETF, it's a popular collaborator in the biopharma sector, and its positioning at the intersection of biotechnology, artificial intelligence (AI), and laboratory robotics means that it's exposed to a lot ...
motleyfoolusx:dna
